#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Peripheral T-cell lymphoma unspecified Dermatitis Interstitial lung disease Round cell liposarcoma PIK3CA related overgrowth spectrum Inborn error of metabolism Nasopharyngeal cancer Autoimmune myositis Langerhans' cell histiocytosis Polyneuropathy Mantle cell lymphoma stage III Glycogen storage disease type II Oesophageal carcinoma Turner's syndrome Angiosarcoma metastatic More trials…

    Learn about Rare Diseases

    Prader-Willi syndrome – Diagnostics Anaplastic thyroid cancer – Trials in Disease Acute respiratory distress syndrome Acute respiratory distress syndrome – Trials in Disease Pulmonary sarcoidosis – Diagnostics IgA nephropathy – Trials in Disease Loeys-Dietz syndrome – Treatment Hyperoxaluria Gastrointestinal stromal tumour Stevens-Johnson syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glycine Volrustomig Ima203Cd8 Octreotide Metreleptin Neratinib Azd3427 Gemtuzumab Ozogamicin Sodium Valproate Paroxetine PICLIDENOSON Menotrophin Ecoo18A Taplucainium Chloride Mps-102 BENZYLPENICILLIN POTASSIUM Olopatadine Budesonide Stiripentol Prasugrel More therapies…

    Learn about Your Condition

    Tuberous sclerosis complex Myelodysplastic syndrome Lung adenocarcinoma stage III Pelvic venous thrombosis Chondrosarcoma Macular telangiectasia Traumatic pain Laryngeal cancer stage II Chronic kidney disease Post cardiac arrest syndrome Metastases to biliary tract Corneal graft rejection Cardiac amyloidosis Peptostreptococcus infection Arterial tortuosity syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study evaluating the effectiveness of cineole compared to mupirocin in patients with chronic Staphylococcus aureus infection or carriage in the nasal cavity.

    Not yet recruiting

    3 1 1 1
    Poland

  • A study comparing bimekizumab and adalimumab for treating chest pain in patients with active axial spondyloarthritis who do not respond well to non-steroidal anti-inflammatory drugs.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Adalimumab
    • Bimekizumab
    France

  • A study to optimize the delivery of AAV2-GDNF and gadoteridol into the brain for patients with Parkinson’s disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 2 Encoding Glial Cell Line-Derived Neurotrophic Factor
    • Gadoteridol
    Poland

  • Study of ASP-1929 and pembrolizumab for patients with recurrent head and neck squamous cell carcinoma without distant metastases

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Docetaxel
    Poland

  • A study of botulinum toxin type A versus placebo to treat bowel movement problems in patients recovering from surgery for rectal cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Botulinum Toxin Type A
    Belgium

  • Study of the effectiveness and safety of colesevelam hydrochloride for patients with moderate-to-severe bile acid diarrhoea.

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • COLESEVELAM HYDROCHLORIDE
    • Loperamide Hydrochloride
    Italy
Previous Page
1 … 727 728 729 730 731 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!